Introduction: practical safety panel screening utilizes useful assays, kinase/transporter profiling, and Sophisticated visualization to detect off-goal liabilities early, increasing preclinical protection assessments. Just final 7 days, a late-phase drug prospect unexpectedly confirmed ad